Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors

Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor

(2012) Xun Xu et al.   CELL

Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm

(2012) Yong Hou et al.   CELL

Circulating tumour cells in non-metastatic breast cancer: a prospective study

(2012) Anthony Lucci et al.   LANCET ONCOLOGY

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

(2012) Marco Gerlinger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device

(2012) Brian J. Kirby et al.   PLoS One

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

(2011) Areti Strati et al.   BMC CANCER

Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors

(2011) M. S. Khan et al.   CLINICAL CANCER RESEARCH

Molecular Characterization of Circulating Tumor Cells in Breast Cancer by a Liquid Bead Array Hybridization Assay

(2011) A. Markou et al.   CLINICAL CHEMISTRY

Chromogranin A and Neuron-Specific Enolase as Prognostic Markers in Patients with Advanced pNET Treated with Everolimus

(2011) James C. Yao et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

(2011) Gilbert Spizzo et al.   JOURNAL OF CLINICAL PATHOLOGY

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

(2011) Matthew G. Krebs et al.   Journal of Thoracic Oncology

Tumour evolution inferred by single-cell sequencing

(2011) Nicholas Navin et al.   NATURE

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

(2011) Eric Raymond et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

(2011) James C. Yao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease

(2010) Irvin M. Modlin et al.   ANNALS OF SURGICAL ONCOLOGY

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

(2010) N C Turner et al.   BRITISH JOURNAL OF CANCER

Increased EpCAM expression in malignant insulinoma: potential clinical implications

(2010) Andreas Raffel et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

(2009) S. J. Cohen et al.   ANNALS OF ONCOLOGY

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

(2009) Anja Rinke et al.   JOURNAL OF CLINICAL ONCOLOGY

Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device

(2009) A. H. Talasaz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

(2008) J. S. de Bono et al.   CLINICAL CANCER RESEARCH

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

(2008) Steven J. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY